Activity of combined therapy with bevacizumab (BV) and paclitaxel (P) in HER2/neu negative patients with widely disseminated metastatic breast cancer (WDMBC). Background: Triple-negative breast ...
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma We analyzed a consecutive series of 507 ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Omission of completion axillary lymph node dissection did not increase recurrence among patients ...
There is increasing evidence to include combined neoadjuvant chemoradiotherapy (CRT) as an alternative to surgical resection alone, to improve survival for locoregional esophageal cancer. More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback